NAV
15.65(-1.38%)Fund Size (CR)
₹340.56Expense Ratio
0.83Scheme Type
Active FundValue Research
-
Min. investment
₹5,000Minimum Additional Investment
₹1,000Minimum SIP Investment
₹1,000Minimum Withdrawal
₹1Exit Load
1%Return Since Launch
18.65%
Basic Details
Scheme Manager
Sandeep Tandon
Bench Mark
NIFTY Healthcare TRI
Type
OPEN
Lumpsum Returns
| Period Invested For | ₹10,000 Invested on | Latest Value | Absolute Returns | Annualised Returns | Category Avg | Rank within Category |
|---|---|---|---|---|---|---|
| 1 Week | 20 February 2026 | 10129.11 | 1.29% | - | -0.44% | 125/987 |
| 1 Month | 27 January 2026 | 10703.37 | 7.03% | - | 2.80% | 154/964 |
| 3 Month | 27 November 2025 | 9828.68 | -1.71% | - | -2.21% | 457/944 |
| 6 Month | 26 August 2025 | 10132.39 | 1.32% | - | 1.81% | 493/916 |
| 1 Year | 27 February 2025 | 11300.21 | 13.00% | 13.00% | 16.10% | 516/848 |
| 3 Year | - | - | - | - | - | -/- |
| 5 Year | - | - | - | - | - | -/- |
| Since Inception | 17 July 2023 | 15650.90 | 56.51% | 18.65% | 11.02% | 153/987 |
Note: Lumpsum Returns since Inception Date.
SIP Returns
| Period Invested For | ₹10,000 Invested on | Investments | Latest Value | Absolute Returns | Annualised Returns |
|---|---|---|---|---|---|
| 1 Year | 3 March 2025 | 1,20,000 | 122974.02 | 2.48% | 2.48% |
| 3 Year | 1 August 2023 | 3,10,000 | 341472.98 | 10.15% | 3.28% |
| 5 Year | - | - | - | - | - |
| 10 Year | - | - | - | - | - |
Note: SIP Returns since Inception Date.
Tax Treatment
If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 10%, if your total long term capital gain exceeds 1 lakh. Any cess/surcharge is not included.If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 15%. Any cess/surcharge is not included in the 15%.
Mutual Funds Calculator
Monthly Investment (₹)
Expected Returns Rate (%)
Time Period (in Years)
Invested Amount
₹25,000
Estimated Returns
₹19,059
76%
Returns
Future value of your investment
₹44,059
Risk Ratios
5.27%
Standard Deviation
0.87%
Beta
0.73%
Sharpe Ratio
-0.02%
Treynor's Ratio
1.24%
Jension's Alpha
Asset Allocation
Sector Allocation
Top 10 stock holding in portfolio
| Stock Invested in | % of Total Holdings | Quantity | Value (Cr) | Asset Type | Segment |
|---|---|---|---|---|---|
| Viyash Scientifi | 8.83% | 1477126 | 30.08 | Equity | Pharmaceuticals |
| Zydus Wellness | 8.45% | 641730 | 28.77 | Equity | FMCG |
| SMS Pharma. | 8.44% | 908071 | 28.75 | Equity | Pharmaceuticals |
| Aurobindo Pharma | 7.71% | 217300 | 26.24 | Equity | Pharmaceuticals |
| Aster DM Health. | 7.24% | 446671 | 24.66 | Equity | Healthcare |
| Alivus Life | 6.95% | 246298 | 23.67 | Equity | Pharmaceuticals |
| Pfizer | 6.43% | 47954 | 21.88 | Equity | Pharmaceuticals |
| Anthem Bioscienc | 5.87% | 333554 | 19.99 | Equity | Pharmaceuticals |
| Adani Enterp. | 5.64% | 94996 | 19.19 | Equity | Trading |
| Divi's Lab. | 3.63% | 20424 | 12.36 | Equity | Pharmaceuticals |
Peer Comparison
| Scheme Name | Value Research | Asset Size (Cr) | 1M | 3M | 6M | 1Y | 3Y |
|---|---|---|---|---|---|---|---|
| Quant Healthcare Fund - Direct (G) | 340.56 | 7.03% | -1.71% | 1.32% | 13.00% | - | |
| Nippon India Taiwan Equity Fund - Direct (G) | 448.04 | 17.96% | 33.40% | 53.02% | 100.62% | 45.69% | |
| Nippon India Taiwan Equity Fund - Direct (IDCW) | 448.04 | 17.96% | 33.40% | 53.02% | 100.62% | 45.69% | |
| HDFC Defence Fund - Direct (G) | 7793.88 | 8.24% | 3.24% | 8.83% | 49.84% | - | |
| HDFC Defence Fund - Direct (IDCW) | 7793.88 | 8.24% | 3.24% | 8.83% | 49.84% | - | |
| Franklin Asian Equity Fund - Direct (G) | 371.57 | 5.18% | 16.09% | 26.14% | 40.83% | 17.86% |
List of Schemes under Quant Mutual Fund
News
Quant Mutual Fund announces change in fund manager under its schemes
Quant Mutual Fund has announced change in fund manager under the following schemes, With effect from 20 February 2026.Change in Fund Manager:
Scheme Name Existing Money Managers [Fund Managers] Revised Money Managers [Fund Managers] Quant Aggressive Hybrid Fund - Sandeep Tandon
- Ankit Pande
- Lokesh Garg
- Varun Pattani
- Ayusha Kumbhat
- Yug Tibrewal
- Sameer Kate
- Sanjeev Sharma- Sandeep Tandon
- Ankit Pande
- Varun Pattani
- Ayusha Kumbhat
- Yug Tibrewal
- Sameer Kate
- Sanjeev Sharma
- Jignesh ShahQuant Business Cycle Fund - Sandeep Tandon
- Ankit Pande
- Lokesh Garg
- Varun Pattani
- Ayusha Kumbhat
- Yug Tibrewal
- Sameer Kate
- Sanjeev Sharma- Sandeep Tandon
- Ankit Pande
- Varun Pattani
- Ayusha Kumbhat
- Yug Tibrewal
- Sameer Kate
- Sanjeev Sharma
- Jignesh ShahQuant Flexi Cap Fund - Sandeep Tandon
- Ankit Pande
- Lokesh Garg
- Varun Pattani
- Ayusha Kumbhat
- Yug Tibrewal
- Sameer Kate
- Sanjeev Sharma- Sandeep Tandon
- Ankit Pande
- Varun Pattani
- Ayusha Kumbhat
- Yug Tibrewal
- Sameer Kate
- Sanjeev Sharma
- Jignesh ShahQuant Focused Fund - Sandeep Tandon
- Ankit Pande
- Lokesh Garg
- Varun Pattani
- Ayusha Kumbhat
- Yug Tibrewal
- Sameer Kate
- Sanjeev Sharma- Sandeep Tandon
- Ankit Pande
- Varun Pattani
- Ayusha Kumbhat
- Yug Tibrewal
- Sameer Kate
- Sanjeev Sharma
- Jignesh ShahQuant Infrastructure Fund - Sandeep Tandon
- Ankit Pande
- Lokesh Garg
- Varun Pattani
- Ayusha Kumbhat
- Yug Tibrewal
- Sameer Kate
- Sanjeev Sharma- Sandeep Tandon
- Ankit Pande
- Varun Pattani
- Ayusha Kumbhat
- Yug Tibrewal
- Sameer Kate
- Sanjeev Sharma
- Jignesh ShahQuant Large Cap Fund - Sandeep Tandon
- Ankit Pande
- Lokesh Garg
- Varun Pattani
- Ayusha Kumbhat
- Yug Tibrewal
- Sameer Kate
- Sanjeev Sharma- Sandeep Tandon
- Ankit Pande
- Varun Pattani
- Ayusha Kumbhat
- Yug Tibrewal
- Sameer Kate
- Sanjeev Sharma
- Jignesh ShahQuant Manufacturing Fund - Sandeep Tandon
- Ankit Pande
- Lokesh Garg
- Varun Pattani
- Ayusha Kumbhat
- Yug Tibrewal
- Sameer Kate
- Sanjeev Sharma- Sandeep Tandon
- Ankit Pande
- Varun Pattani
- Ayusha Kumbhat
- Yug Tibrewal
- Sameer Kate
- Sanjeev Sharma
- Jignesh ShahQuant Multi Cap Fund - Sandeep Tandon
- Ankit Pande
- Lokesh Garg
- Varun Pattani
- Ayusha Kumbhat
- Yug Tibrewal
- Sameer Kate
- Sanjeev Sharma- Sandeep Tandon
- Ankit Pande
- Varun Pattani
- Ayusha Kumbhat
- Yug Tibrewal
- Sameer Kate
- Sanjeev Sharma
- Jignesh ShahQuant Gilt Fund - Sanjeev Sharma
- Harshvardhan Bharatia- Sanjeev Sharma
- Haroonvardhan SirohiQuant Liquid Fund - Sanjeev Sharma
- Harshvardhan Bharatia- Sanjeev Sharma
- Haroonvardhan SirohiQuant Overnight Fund - Sanjeev Sharma
- Harshvardhan Bharatia- Sanjeev Sharma
- Haroonvardhan SirohiQuant Arbitrage Fund - Sameer Kate
- Yug Tibrewal
- Sanjeev Sharma- Sameer Kate
- Yug Tibrewal
- Sanjeev Sharma
- Harshvardhan BharatiaPowered by Capital Market - Live News
Quant Mutual Fund announces change in Key Personnel
Quant Mutual Fund has announced that, Mr. Mahendra Kumar Jajoo (DIN: 06966229) has been appointed as Whole Time Director on the Board of quant Money Managers Limited (Asset Management Company to the Fund) with effect from January 14, 2026.Details of Mr. Mahendra Kumar Jajoo
Age: 57 years
Designation: Whole Time Director
Qualification: B. Com, ACA, ACS, CFA (USA)
Powered by Capital Market - Live News
Fund House Details & Investment Objective
Date of Incorporation
27 June 2023
Total AUM (Cr)
₹340.56
Quant Healthcare Fund - Direct (G) is an Sectoral / Thematic-oriented fund from the renowned AMC, Quant Mutual Fund. Launched in 27 June 2023, this fund is managed by Sandeep Tandon. With assets under management (AUM) worth ₹340.56 (Cr), as of 27 February 2026, Quant Healthcare Fund - Direct (G) is categorized as a Sectoral / Thematic within its segment. The fund has generated a return of 18.65% since its launch.
The current NAV of Quant Healthcare Fund - Direct (G) is ₹15.65, as on 27 February 2026. The fund's benchmark index is NIFTY Healthcare TRI. You can invest in Quant Healthcare Fund - Direct (G) via both lumpsum and SIP modes. The minimum SIP amount in the fund is ₹1,000 while the minimum lumpsum investment is ₹5,000.
Being an open-ended fund, you can exit the fund anytime subject to applicable exit loads:
The fund has generated undefined% and undefined% CAGR in the last 3 and 5 years respectively.
The fund aims to provide long-term capital appreciation and growth, by investing in a mix of financial instruments 77.63% in Equity, 19.14% in Debt and 3.23% in cash and cash equivalents.
The top 5 sectors the fund invests in are: 62.06% in Pharmaceuticals & Biotech, 11.25% in Others, 10.31% in Debt, 8.05% in Food Products, 7.60% in Healthcare Services
